Plasma-derived product · Immune activation, directed at cytomegalovirus · developed by Kamada
Human Cytomegalovirus Immune Globulin is a sterilized solution of immunoglobulins against cytomegalovirus (CMV), derived from human plasma of CMV-infected donors. It is used for passive immunization to help prevent or treat CMV infection and is studied in CMV infection.
Summary written with AI from the sources listed at the end of this page.
| Trial | Phase | Condition | Status | Sponsor |
|---|---|---|---|---|
| NCT07009548 | Phase 4 | Cytomegalovirus (CMV) Infection | Enrolling by invitation | KMDA |
Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.
Cytomegalovirus (CMV) Infection
Updated Oct 18, 2026. Something wrong or missing? Report it on the KMDA page.
See KMDA's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.
KMDA catalysts and pipeline →